Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
A genome‐wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi‐kinase inhibitors in hepatocellular carcinoma cells - Sofer - 2022 - The FASEB Journal - Wiley Online Library
Collaterals
A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic sol
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
PDF) Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects | Shlomit Perry, Ruth Pat-Horenczyk, Yuval Ziv, Salomon Stemmer, and Yaira Hamama-raz - Academia.edu
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Pasireotide for malignant insulinoma
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Cetuximab intensifies cisplatin-induced testicular toxicity
Staphylococcus Coagulase‐Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor‐Targe
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Phase II organâ•'preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single C
